Artrya’s coronary diagnostic product has been given regulatory approval for use in the UK after being knocked back by the US Food and Drug Administration five months ago.
07/11/2022 - 15:32
Artrya gets UK break
07/11/2022 - 15:32
![](https://images.businessnews.com.au/images/bn2020/bubble-arrow-border.png)